NextGxDx.png
Company Profile:

NextGxDx

Based on the success of online marketplaces such as Amazon, NextGxDx was founded to be a single, definitive source for finding and ordering the appropriate genetic test. With more than 19,000 genetic tests and 250 CLIA-certified laboratories available in the US, finding and ordering the right test has become a challenge for healthcare professionals and hospitals. With scattered information about genetic tests, inconsistent ordering processes, and cumbersome result reporting, there is a growing need for tools to navigate this explosive field. NextGxDx’s software discovers, indexes, and curates genetic test information from across the web, and provides an intelligent search engine specifically designed for genetic testing. Leveraging this database, NextGxDx has built an online marketplace that allows hospitals and healthcare providers to search, compare, and order genetic tests and to receive results electronically within the HIPAA-compliant platform. NextGxDx’s newest product, GeneConnectTM, provides hospitals and sendout laboratories with the tools to lower costs and address workflow inefficiencies associated with the genetic test ordering process. As the genetic testing resource, NextGxDx provides comprehensive, intuitive solutions that address the specific challenges faced by each segment of the genetics industry. To learn more about NextGxDx or GeneConnect, visit: https://www.NextGxDx.com.

Leadership:
Jay Buford
SVP of Business Development
Mark Harris
CEO
2014 Active Partner Page Bio Tech, Information Technology View Website
NextGxDx_jay.jpg
Entrepreneur Profile:

Jay Buford
SVP of Business Development
With a deep background in sales, channel partner and strategic alliance development, SaaS technology, and consumer products, Jay brings over 30 years of relevant business experience to the NextGxDx team. Focused on long term relationships, Jay enjoys working with business partners to provide customers increased value through the integration of accretive products and services. Jay spent 18 years with the world’s largest provider of kidney dialysis where he was involved in the development, sales and implementation of some of the earliest laboratory management software. He has led the Merger & Acquisition efforts of multiple companies, resulting in the acquisition and integration of more than 30 companies in his career. In 2011, as EVP and a member of the executive team, he led the successful sale of his Chicago-based technology company to a private equity firm. On the personal side, Jay is a USCG licensed Captain and avid big-game offshore fisherman and scuba diver. Additionally, he holds a 2nd Degree Black Belt in Wado-Ryu Karate, and enjoys fly-fishing, tennis, golf, and playing baseball almost as well as he did in college at The University of Tennessee-Martin.
Company: Back
NextGxDx.png 2014 Active Partner Page
NextGxDx_Harris_Mark.jpg
Entrepreneur Profile:

Mark Harris
CEO
As founder and CEO, Dr. Harris has led NextGxDx’s mission to assist clinicians and hospitals with tools to easily search, compare, and order genetic tests. The technology developed to support this mission has been used to organize and curate over 19,000 individual tests, leading to a more transparent and efficient market. Prior to forming NextGxDx, Dr. Harris led a project within Athena Diagnostics in 2010 to integrate Next Generation Sequencing technology into Athena’s clinical workflow. He was placed in this project through ThermoFisher Scientific's leadership development program. Dr. Harris is deeply involved in the entrepreneurial ecosystem, and mentors two startup accelerator programs: JumpStart Foundry and HealthBox. He also serves on the Advisory Board for Vanderbilt University's Center for Technology Transfer and Commercialization. Dr. Harris has been recognized as one of Nashville's Forty Under 40, and was awarded as one of 25 Health Care Heroes selected by the Chamber of Commerce for his contributions and leadership in the community. Dr. Harris earned three degrees from Vanderbilt University: a BS in Molecular and Cellular Biology, a PhD in Cancer Biology, and a MBA from the Owen Graduate School of Management.
Company: Back
NextGxDx.png 2014 Active Partner Page